Evolent Health Inc(EVH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -4.57 | Insider Own | 9.42% | Shs Outstand | 112.7M | Perf Week | -1.42% |
| Market Cap | 0.47B | Forward P/E | 11.94 | EPS next Y | 102.38% | Insider Trans | -0.61% | Shs Float | 102.4M | Perf Month | 1.71% |
| Enterprise Value | 1.30B | PEG | 0.16 | EPS next Q | 0.06 | Inst Own | 94.49% | Short Float | 15.4% | Perf Quarter | -6.71% |
| Income | -0.51B | P/S | 0.22 | EPS this Y | 91.7% | Inst Trans | 1.71% | Short Ratio | 5.2 | Perf Half Y | 38.08% |
| Sales | 2.10B | P/B | 1.23 | EPS next 5Y | 74.67% | ROA | -22.78% | Short Interest | 15.77M | Perf YTD | 4.25% |
| Book/sh | 3.4 | P/C | 3.4 | EPS past 3/5Y | -194.21% -5.21% | ROE | -78.95% | 52W High | -58.55% ($10.06) | Perf Year | -54.62% |
| Cash/sh | 1.23 | P/FCF | 19.37 | Sales past 3/5Y | 11.54% 15.2% | ROIC | -37.35% | 52W Low | 99.05% ($2.10) | Perf 3Y | -83.65% |
| Dividend Est. | - | EV/EBITDA | 14.8 | EPS Y/Y TTM | -184.71% | Gross Margin | 11.89% | Volatility(W/M) | 5.66% 6.67% | Perf 5Y | -83.45% |
| Dividend TTM | - | EV/Sales | 0.62 | Sales Y/Y TTM | -4.5% | Oper. Margin | -1.33% | ATR (14) | 0.3 | Perf 10Y | -81.39% |
| Dividend Ex-Date | - | Quick Ratio | 1.24 | EPS Q/Q | 42.84% | Profit Margin | -24.37% | RSI (14) | 42.96 | Recom | 1.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.24 | Sales Q/Q | 46.86% | SMA20 | -7.54% ($4.51) | Beta | 1.01 | Target Price | $5.77 |
| Payout | - | Debt/Eq | 2.53 | Earnings | 2026/8/6 | SMA50 | -10.07% ($4.64) | Rel Volume | 0.45 | Prev Close | $4.15 |
| Employees | 4200 | LT Debt/Eq | 2.53 | EPS/Sales Surpr. | 292.31% 9.17% | SMA200 | 7.97% ($3.86) | Avg Volume(3M) | 3.03M | Price | $4.17 |
| IPO | 2015/6/5 | Option/Short | Yes/Yes | Trades | 7497 | Volume | 1,373,019 | Change | 0.48% |
Company
EVH is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
Evolent Health trades under the ticker EVH and is a U.S. healthcare technology and services company focused on value-based care. It provides care management and administrative solutions to payers and provider organizations across specialty areas such as oncology, cardiology, and musculoskeletal care. Its business model is built around a data-driven platform designed to reduce medical costs while simultaneously improving the quality of care.
Over the past 1 year, roughly in the middle
59% below its 1-year high.
EVH has weak earning power
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +91.7% this year.
Tap to view numbers
The stock looks undervalued
Trading at - times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -83.7% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 94.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
UN 0.01%
HEAL 0.01%
VFVA 0.00%
SCDS 0.00%
HAPS 0.00%It ranks #4 in the industry
Based on market cap of $471M.
EVH $471M PER -
VEEV $42B PER 42.9
BTSG $11B PER 43.2
TEM $11B PER -
FAQ
What kind of company is EVH?
EVH belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of EVH?
The market cap of EVH is approximately $471M, ranking 3,272 within its sector.
What is the 52-week high and low for EVH?
EVH has recorded a 52-week high of $10.06 and a low of $2.10.
